
Investors
News Release Details
Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release
Opiant had no knowledge of the press release issued by Cision PR Newswire, and it is fake. Opiant and
Cision PR Newswire issued a notice across its service confirming that journalists, investors and other readers should disregard the news release, "
All further questions should be directed to Cision PR Newswire.
For Media and Investor Inquiries:
(310) 598-5410
batkins@opiant.com
View original content:https://www.prnewswire.com/news-releases/opiant-pharmaceuticals-issues-statement-in-response-to-fake-press-release-301536458.html
SOURCE